Btc Biliary Tract Cancer clinical trials

Explore recruiting btc biliary tract cancer clinical trials.

Recruiting btc biliary tract cancer studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Btc Biliary Tract Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An open-label randomized trial of the efficacy and safety of zanidatamab with standard-of-care therapy against standard of-care therapy alone for advanced HER2 positive biliary tract cancer

Germany, Belgium, Spain, Finland, Czechia, France +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Btc Biliary Tract Cancer trials by city

Btc Biliary Tract Cancer clinical trials

Recruiting btc biliary tract cancer studies right now

Paclitaxel mIcelle Later-line cOmbined immunoTherapy for Biliary Tract Cancer

A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)

CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative Chemotherapy Versus Immediate Resection in patIents With resecTable BiliarY Tract Cancers (BTC) at High Risk for Recurrence

Cosiporfin Sodium for Injection Photodynamic Therapy

A Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing Chemotherapy Versus Durvalumab in Combination With Platinum-Containing Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer (BTC)

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer

Also recruiting in Europe

An open-label randomized trial of the efficacy and safety of zanidatamab with standard-of-care therapy against standard of-care therapy alone for advanced HER2 positive biliary tract cancer

Btc Biliary Tract Cancer trials by city

Other conditions